UOC
BNTX icon

UBS O'Connor’s BioNTech BNTX Stock Holding History

UBS O'Connor’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,363
Closed -$460K – 529
2023
Q4 		$460K Buy
4,363
+363
+9% +$36.6K 0.01% 359
2023
Q3 		$435K Buy
+4,000
New +$442K 0.01% 412
2021
Q3 		– Sell
-5,000
Closed -$1.12M – 926
2021
Q2 		$1.12M Buy
+5,000
New +$943K 0.01% 543

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

UBS O'Connor's BNTX Position: Q1 2024 in Review

UBS O'Connor sold out of BioNTech (BNTX) in Q1 2024, closing a stake of 4,363 shares — an estimated $460K sold.

UBS O'Connor first reported a position in BNTX in Q2 2021 and held it in 3 quarters. The position peaked at $1.12M in Q2 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

  • UBS O'Connor reported no remaining BioNTech position as of Q1 2024 after selling out during the quarter.
  • UBS O'Connor sold 4,363 BioNTech shares in Q1 2024, an estimated $460K.
  • UBS O'Connor first reported a position in BioNTech in Q2 2021 and held it in 3 quarters.
  • UBS O'Connor's BioNTech position peaked at $1.12M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.